$Diamedica疗法(DMAC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001235802-21-000100 Size: 6 KB 网页链接
$Diamedica疗法(DMAC)$ 内部交易: 2021-08-16,总裁 and CEO,Pauls Dietrich John ,买入,5000普通股, $3.14
$Diamedica疗法(DMAC)$ 内部交易: 2021-08-16,高级VP, Clinical Operations,ALCORN HARRY W JR ,买入,399普通股, $3.07
$Diamedica疗法(DMAC)$ 内部交易: 2021-08-16,高级VP, Clinical Operations,ALCORN HARRY W JR ,买入,20322普通股, $3.09
$Diamedica疗法(DMAC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001235802-21-000099 Size: 7 KB 网页链接
$Diamedica疗法(DMAC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001235802-21-000098 Size: 5 KB 网页链接
$Diamedica疗法(DMAC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001235802-21-000097 Size: 4 KB 网页链接
$Diamedica疗法(DMAC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-019477 Act: 34 Size: 197 KB 网页链接
$Diamedica疗法(DMAC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-019480 Act: 34 Size: 4 MB 网页链接
$Diamedica疗法(DMAC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001235802-21-000093 Size: 5 KB 网页链接